FIGURE 4.
Antibody potency of mature hu3F8 IgG1 in ADCC against neuroblastoma. A and B, three hu3F8 variants mediate in vitro ADCC on LAN-1 neuroblastoma cells with human PBMC (A) and NK92-CD16 (B) effector cells.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.